|Articles|February 1, 2017
- Pharmaceutical Executive-02-01-2017
- Volume 37
- Issue 2
Pharmaceutical Executive, February 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Region in Reform? Access Pains and Gains in Latin Americaover 9 years ago
CMED: The ‘Curupira’ of Brazil’s Pharma Marketover 9 years ago
The Trouble with Pharma Partnerships ... And How to Fix Themover 9 years ago
Reducing the Risk of Noncomplianceover 9 years ago
When You Need Experts, Use Themover 9 years ago
Pricing Pressures and Policy Changesover 9 years ago
Not Your Typical Pharma Datelineover 9 years ago
Market Access: Current and Future Statesover 9 years ago
Market Access: A UK Perspectiveover 9 years ago
Country Report: SingaporeAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
3
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
4
What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?
5